TG-4318

N/A

Report date: 2025/12/02 14:07:53
NME

Base Information

Drug NameTG-4318
Drug Alias NameTG-4318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin C inhibitors
TargetsCathepsin C
Therapy Area/IndicationsBronchiectasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTaigen Pharmaceutical R & D (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJoincare Pharmaceutical Group Industry Co LtdTaigen Pharmaceutical R & D (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsBronchiectasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A